This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Wake Forest University. Active years: 2018-2023.
Company Filing History:
Years Active: 2018-2023
Title: The Innovative Contributions of Sara Ferluga
Introduction
Sara Ferluga is a prominent inventor based in Trieste, Italy. She has made significant contributions to the field of cancer treatment through her innovative research and patented inventions. With a total of 3 patents, her work focuses on the development of constructs that target tumors effectively.
Latest Patents
Among her latest patents is a groundbreaking construct that combines an EphA3, EphA2, and/or EphB2 binding ligand with at least one effector molecule. This effector molecule can include a therapeutic agent, a nanoparticle, a detectable group, a lipid, or a liposome. In some embodiments, the construct is designed as a fusion protein or a covalent conjugate. Additionally, she has developed a construct that includes a ligand binding to EphA2, EphA3, and/or EphB2, along with a ligand that binds to IL-13Rα2, and at least one effector molecule. These inventions provide methods for treating cancer, showcasing her commitment to advancing medical science.
Career Highlights
Sara Ferluga is affiliated with Wake Forest University, where she continues her research and development efforts. Her work has garnered attention for its potential impact on cancer therapies, making her a valuable asset in the scientific community.
Collaborations
Sara collaborates with esteemed colleagues such as Waldemar Debinski and Carla Lema Tome. Their combined expertise enhances the research initiatives they undertake, contributing to the advancement of cancer treatment methodologies.
Conclusion
Sara Ferluga's innovative work in cancer treatment through her patented inventions highlights her significant role in the field. Her contributions are paving the way for new therapeutic approaches that could benefit many patients in the future.